Overview

Efficacy of Deutetrabenazine to Control Symptoms of Dysphagia Associated With HD

Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To determine the efficacy of deutetrabenazine to control symptoms of dysphagia associated with HD.
Phase:
Phase 1
Details
Lead Sponsor:
Fundacion Huntington Puerto Rico
Treatments:
Tetrabenazine